Clinical Trial Detail

NCT ID NCT02387216
Title A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Merrimack Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Seribantumab

Pemetrexed Disodium

Docetaxel

Age Groups: adult

Additional content available in CKB BOOST